Newsletter | May 1, 2025

05.01.25 -- Why Aren't We Using More Wearables In Clinical Trials?

FEATURED EDITORIAL

Why Aren't We Using More Wearables In Clinical Trials?

Wearables provide a great means for passive data collection in clinical trials, but implementing them isn’t as easy as it seems. Lauren Sunshine, director, product management, digital health, at BMS, talks about some of the advantages — and challenges — of incorporating DHTs into your trial protocols. 

INDUSTRY INSIGHTS

Evolving Data Review With AI

AI is transforming clinical data review by automating processes. Discover the four stages of evolution that emphasize automation, regulatory alignment, data analysis, and human oversight.

Right-Size Your eConsent Approach

Delve into the art of tailoring the eConsent experience to match your study and patients' specific needs, such as crafting eConsent documents, selecting appropriate delivery models, and more.

How Digitized Protocols Are Accelerating Clinical Research

Digitized protocols, enhanced by artificial intelligence (AI), are transforming clinical trial operations by accelerating document generation, system integration, and trial optimization.

The Catch-22 Of eConsent: A Missed Opportunity For Improved Trials

Drawing on evidence from scientific literature, we examine the pitfalls that have hindered its success and propose actionable solutions to unlock its true value in clinical research.

Planning Ahead: 5 Best Practices For The Integration Of Wearables

Prioritize the considerations outlined by the author to plan effectively, optimize wearable data utility, and significantly enhance your trial outcomes.